Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Metformin and Cholecystokinin on GLP-1 in Type 2 Diabetes
NCT02497313Completed
- Sponsor
- Gentofte Hospital
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of metformin and cholecystokinin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Gentofte Hospital. Primary endpoint: Glucagon-like peptide-1 Incremental and total area under the Concentration-Time Curve. Started Jul 2015; status: completed.
02
Drugs
metformincholecystokinin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02497313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02497313.